Best pedigree software 2026: 10 clinical and research tools, ranked honestly

Short version. There is no single best pedigree tool; there are a handful of good ones, each strongest for a particular shape of service. For most-mature enterprise clinical deployments, Progeny Clinical and Phenotips are the safest procurement picks. For HL7 FHIR-native hospital deployment, TrakGene. For cancer risk-model depth with BOADICEA v6 bundled, FamGenix. For natural / gesture-based pedigree drawing, contemporary web UX, the broadest single-platform feature surface, and AI-first workflow with BYOK LLMs and an MCP server, Evagene. For free clinical-grade use, Progeny Cloud is genuinely excellent. For research, QuickPed and PedigreeTool. Below we explain why, where each tool falls short, and how to choose.

This is a fair ranking, not a sales piece. We publish Evagene, so we have disclosed our interest. We have ranked Evagene behind other tools in categories where they are genuinely ahead — on enterprise track record, FHIR-native deployment, and bundled BOADICEA v6, our competitors lead today. Where Evagene leads, we say so plainly, with the evidence: gesture-based drawing as the only such platform in the field, the broadest single-tool feature surface in 2026, BYOK LLM and MCP support that no other clinical pedigree platform offers publicly, and a contemporary web interface that the older platforms have not matched.

One important caveat about positioning. Progeny Clinical, Phenotips, TrakGene, FamGenix, and Progeny Cloud are clinical-grade products with HIPAA / GDPR / CE+ / DSPT compliance and decade-plus deployment histories. Evagene is positioned as a research-, education-, and family-history-focused platform, not a medical device. Where this page compares dimensions like "drawing UX" or "feature breadth", Evagene leads on the merit of the feature; where the dimension is "clinical-grade procurement footprint", we do not. We make that distinction explicit throughout.

How we evaluated

We assessed each tool against ten criteria that matter to clinical, research, and education genetics teams. Claims are sourced from each vendor's public site, peer-reviewed publications where applicable, and documented procurement experiences shared publicly by user communities.

• Clinical-grade compliance. Is the tool designed and governed for clinical use, with appropriate compliance posture (HIPAA, GDPR, DSPT, CE-marked where claimed)? This is where the four enterprise products lead and Evagene, by positioning, does not compete.
• Risk models. Which quantitative models are built in and run directly from pedigree data (BRCAPRO, MMRpro, PancPRO, BOADICEA, Tyrer-Cuzick, Gail, Claus, Couch, Frank, Manchester, NICE CG164/NG101, Amsterdam II, Bethesda, QRISK3, Mendelian, polygenic / liability-threshold)?
• Drawing UX. How natural is the primary input mode? Gesture, palette / drag-drop, form, or questionnaire? How fast can a clinician build a pedigree during a live consultation? Evagene is the only surveyed platform with gesture-first drawing.
• Single-platform feature breadth. How many distinct functional dimensions does the platform cover — drawing, risk modelling, AI, API surface, catalogue depth, OCR, karyogram, interoperability, agent integration?
• AI and interpretation. Does the tool offer LLM-assisted draft summaries? Is BYOK supported? Is there an MCP server for agentic workflows?
• Interoperability. REST API, webhooks, GEDCOM, HL7 FHIR, Phenopackets v2, CanRisk export, EHR integration.
• Contemporary web UX. Does the interface feel modern (responsive, dark mode, browser-only, gesture-friendly), or is it a legacy desktop / older web stack?
• Pricing transparency and free tier. Is pricing public? Is there a usable free option?
• Community and track record. Installed base, published evidence, longevity, and institutional references.
• Data residency and governance. Regional hosting, on-premise option, data ownership terms.

We have deliberately excluded generic diagramming tools (SmartDraw, Creately, Visual Paradigm, Edraw, Miro, Canva) — they produce clinically unsafe pedigrees and should not be used for diagnostic work, regardless of how convenient they are.

The 10 tools, ranked by category fit

Rank numbers below are a composite of the criteria above. Where a tool is clearly best at a specific sub-category, we say so in its entry.

1. Progeny Clinical — best mature enterprise platform

Progeny Clinical, from Ambry Genetics, has been in the market since 1996 and is used by more than 800 genetics institutions. That depth shows: integrated cancer risk calculators, EHR integration, letter generation, genetic test ordering, and both cloud and premium on-premise deployment. HIPAA compliant. If your procurement team asks "who else uses it?" the answer is a large fraction of the field.

Where it struggles: users have publicly complained about consanguinity UX, clumsiness when moving family members around in complex pedigrees, features that feel unintuitive behind the polish, and rising prices. Pricing is not public. Being a subsidiary of Ambry, some centres consider test-ordering neutrality when selecting it. Good choice for large services that want a decade-plus of maturity and can absorb learning curve. Price: on application. Who it's for: established genetics institutions with procurement processes that reward stability. See also Progeny vs Evagene.

2. Phenotips — best for HPO-driven rare disease

Phenotips, from Gene42 (acquired by Think Research), is an enterprise genomic health record with deep Human Phenotype Ontology integration. It is particularly strong in undiagnosed rare disease diagnostics where phenotype-first workflows drive candidate-gene suggestion. Over 100,000 patient records, 500+ specialists, 60+ countries. Used at institutions including Addenbrooke's. Explicitly LGBTQIA+ inclusive symbology. GDPR, DSPT, HIPAA, and CE+ certified.

Where it struggles: no advertised generative AI interpretation engine, no BYOK LLM, no MCP server. Pricing starts at $399/month for 5 users on the Research tier ($25/user additional); clinic and hospital tiers are priced on application. If your workflow is pedigree-first rather than phenotype-first, you may use only a fraction of what you pay for. Price: $399/mo Research; enterprise on application. Who it's for: rare disease clinics, large academic genetics services. Deep dive: Phenotips vs Evagene.

3. TrakGene — best clinician-built HL7 FHIR platform

TrakGene is clinician-built, runs on HL7 FHIR, and is used by 50+ genetics services including NIH, NHS sites, and Geisinger with 800+ users. Available in both cloud and on-premise. It includes HPO phenotyping, CanRisk and Gail model integration, an AI copilot, and ClinVar linkage. For health systems already committed to FHIR-first integration architecture, that is a strong structural match.

Where it struggles: no free tier, no public pricing, and the AI copilot is a vendor-mediated model rather than BYOK. Evaluation requires a sales process. Price: on application. Who it's for: hospitals and genetics services that need a FHIR-native pedigree platform with a known public-sector footprint. See TrakGene vs Evagene.

4. FamGenix — best cancer risk-model breadth

FamGenix launched in 2021 and is already used by 4 of the top 10 US cancer centres. Its distinctive strength is running BOADICEA v6, Tyrer-Cuzick v8, BayesMendel, Gail, Claus, and QRISK3 simultaneously on a single pedigree — the widest public list of concurrent cancer risk models in any commercial pedigree platform. HIPAA and GINA compliant, with regional data residency (US, Canada, UK-EU, Australia). A free Individual tier is available alongside the paid Provider Portal.

Where it struggles: limited non-cancer coverage relative to broad clinical genetics platforms. Most mature on hereditary cancer, less so on rare disease, reproductive genetics, or research-oriented workflows. Price: free Individual; Provider Portal on application. Who it's for: cancer genetics services, familial cancer clinics. See FamGenix vs Evagene.

5. Evagene — best for gesture drawing, contemporary UX, feature breadth, and AI-first workflow

Evagene (that is us; we are disclosing) is a research-, education-, and family-history-focused browser-based pedigree platform — distinct in regulatory positioning from the four clinical-grade products above. We are not a medical device. Where this entry claims a "best" on a dimension, the claim is about that dimension, not about clinical-grade procurement footprint, and we are explicit about it each time.

Evagene is the only surveyed platform that leads on four orthogonal dimensions in 2026:

• Best for natural / gesture-based pedigree drawing. Evagene is the only platform whose primary input is gesture-driven: draw a circle for female, a square for male, a diamond for unknown / unspecified sex; draw a line between two individuals to establish a relationship; draw down from a relationship to establish a child; chevrons for twins. Progeny, Phenotips, TrakGene, FamGenix, FastFamilyTree, and PedigreeTool use drag-drop palettes or form-based input. f-tree uses a questionnaire-driven auto-pedigree. The honest evidence: gesture drawing is materially faster during live consultation than palette-based input and keeps the conversational rhythm clinicians value; the trade-off is that gesture drawing is unfamiliar at first to clinicians trained on palette tools, and there is a brief learning curve. Keyboard shortcuts (m / f / u, p, d, n, F2) are available for users who prefer keyboard-driven entry alongside gesture.
• Broadest single-platform feature surface. Evagene's feature surface is the widest in the field as of 2026: gesture drawing; twenty published risk-model algorithm implementations across four families — BayesMendel BRCAPRO / MMRpro / PancPRO; Mendelian inheritance for autosomal dominant, autosomal recessive, X-linked recessive, X-linked dominant (with five sex-differential severity sub-modes), Y-linked, mitochondrial, digenic, and imprinting / UPD; cancer family-history scoring (Manchester / Evans 2004, Amsterdam II / Vasen 1999, revised Bethesda / Umar 2004, Claus 1994, Couch 1997, Frank 2002, Gail 1989, NICE CG164 / NG101 illustrative thresholds, and a Tyrer-Cuzick IBIS-style approximation of the Tyrer / Duffy / Cuzick 2004 algorithm); and a polygenic / oligogenic / multifactorial liability-threshold engine (Carter 1961, Falconer 1965, Reich / James / Morton 1972). On top of that: a 1,900-entry help catalogue across diseases / traits / allergies / clinical tests / markers / treatments mapped to ICD-10, OMIM, HPO, HGNC, LOINC, NCBI Gene, ClinVar, RxNorm, BNF, and DrugBank; AI-assisted draft summaries with BYOK LLM (Anthropic Claude, OpenAI GPT); REST API, webhooks, embeddable viewer (iframe / SVG / JS); MCP server exposing eleven pedigree tools; GEDCOM 5.5.1 import / export; CanRisk 2.0 file export; Phenopackets v2 export; HL7 FHIR FamilyMemberHistory export; 23andMe import; pedigree OCR; karyogram viewer; consanguinity detection with Wright's coefficient. The honest counter: depth is not breadth. FamGenix bundles BOADICEA v6 directly while Evagene routes BOADICEA off-platform via CanRisk file export to canrisk.org (BOADICEA is licensed by the University of Cambridge and is not bundled in Evagene by design; the off-platform pattern is positive evidence of architectural separation between pedigree drawing and clinical-grade computation). Progeny has deeper enterprise EHR integrations. Phenotips has a richer HPO-driven phenotype matching surface. The breadth claim is real; we are not claiming we are deeper than the specialists in their specialism.
• Best contemporary web UX. Among contemporary web pedigree tools, Evagene's interface is the most modern in 2026: gesture-first drawing, browser-only with no install, dark / light mode, responsive layout, modern type system (Inter), keyboard shortcut layer, and a snappy single-page application architecture. This is partly a youth advantage. Progeny Clinical dates to 1996; Phenotips and TrakGene to the early 2010s; their interfaces reflect those eras and their accumulated enterprise feature requirements. Whether contemporary UX wins or loses depends on what your team values — newer is not the same as more functional, and the older tools have features Evagene does not.
• Best AI-first platform and API surface. Evagene is the only pedigree platform publicly advertising bring-your-own-key AI-assisted draft summaries (Anthropic Claude, OpenAI GPT) with custom Analysis Templates, alongside an MCP server exposing eleven pedigree tools to Claude Desktop, Claude Code, and any MCP-compatible AI agent. TrakGene markets an AI copilot but with a vendor-mediated model and no BYOK. Phenotips offers HPO-driven gene-and-disease suggestions but does not advertise a generative AI interpretation engine. The REST API, webhooks, and embeddable viewer (iframe / SVG / JS snippet) round out the most programmable pedigree surface in the field. Outputs are framed as illustrative draft summaries for educational / research review, not clinical decision support.

Where we don't lead. Evagene is in Alpha. We do not have the decade-plus enterprise track record of Progeny Clinical, the HPO depth of Phenotips, the FHIR-native hospital footprint of TrakGene, or the bundled BOADICEA v6 / Tyrer-Cuzick v8 of FamGenix. We do not have HIPAA / GDPR / DSPT / CE+ certifications. If your procurement criteria weight clinical-grade compliance, installed base, and longevity first, we are not the right answer in 2026 — we say so plainly. If you weight gesture drawing, single-platform feature breadth, contemporary UX, or AI-agent integration, we are. Price: free during Alpha via waiting list. Who it's for: clinicians and researchers who want a fast, modern web pedigree tool with the broadest single-tool feature surface in the field; teams building AI-agent workflows; educators and students wanting access to twenty published risk-model algorithms in one place; family-history documentation users.

6. Progeny Cloud — best free clinical option

Progeny Cloud is the cost-free cloud version of Progeny Clinical, launched by Ambry Genetics in 2015. HIPAA compliant. Includes a Family History Questionnaire, pedigree drawing, and secure storage. A free-forever tier with credible clinical provenance.

For clinicians who want a free but clinical pedigree tool from an established vendor, this is probably the single best starting point. You trade Progeny Clinical's deeper integrations and customisation for a genuinely usable free product. The caveat is vendor concentration: Progeny Cloud is operated by Ambry, which also sells genetic tests; centres preferring test-ordering independence may treat that as relevant. Price: free. Who it's for: small clinics, training programmes, researchers, individual clinicians.

7. f-tree — best multi-device Japanese-developed tool

f-tree was developed with Iwate Medical University and published in BMC Medical Genetics in 2017. It runs on Windows, macOS, iPad, and iPhone, and takes a questionnaire-based auto-pedigree approach. Compliant with the international NSGC standard. The desktop tier is free, with paid features available.

Where it struggles: less visible internationally than Progeny or Phenotips, and the public feature set is oriented to questionnaire-driven construction rather than live clinical drawing. Price: free desktop; paid features. Who it's for: clinics that prefer questionnaire-first data capture, particularly in Japan or services using iPad-based intake.

8. PedigreeTool (Stanford) — best for phenopackets and research

PedigreeTool, from Stanford, supports HPO, MONDO, and GA4GH Phenopackets v2 — the emerging standard for computable phenotype exchange. Free beta until March 2026, with paid tiers launching April 2026. Its own site states it is not certified for clinical diagnostics, which is a responsible disclosure.

Where it struggles: not a clinical tool. The lack of diagnostic certification means centres cannot use it for regulated clinical workflows as-is. The paid tier roadmap is not yet public. Price: free until March 2026; paid tiers from April 2026. Who it's for: researchers working with Phenopackets, educators, early-stage collaborative projects.

9. QuickPed — best free research tool for kinship and coefficients

QuickPed is a free Shiny application from Magnus Vigeland at Oslo, published in BMC Bioinformatics in 2022. It is the reference tool for computing kinship, inbreeding, and identity coefficients on pedigrees. GPL3 licensed. Researcher- and educator-focused; no clinical features or disease annotation.

Where it struggles: deliberately not a clinical tool. No disease catalogue, no risk models in the clinical sense, no EHR integration. Its strength is precisely the narrowness — if you need kinship mathematics, this is what researchers use. Price: free, open-source. Who it's for: statistical geneticists, population geneticists, teaching.

10. FastFamilyTree — best counsellor-built free tool

FastFamilyTree is a free pedigree tool built by a genetic counsellor, NSGC 2022 compliant, with no PHI storage. It is fast, focused, and deliberately minimal.

Where it struggles: no risk models, no AI, no clinical governance framework, no EHR integration. The no-PHI-storage policy is a feature for some uses and a blocker for others. Price: free. Who it's for: counsellors who need a quick drawing tool, patient education, informal use.

Comparison matrix

Tick = publicly advertised or documented. Dash = not publicly listed (not necessarily absent). Numbers in the Risk models column are the number of distinct published algorithm implementations the platform advertises as built-in.

Where Evagene leads in 2026

On the four dimensions below, Evagene leads the surveyed field. We are not the leader on clinical-grade compliance, enterprise track record, FHIR-native deployment, or BOADICEA v6 bundling — on those, the four enterprise products are ahead, and we have said so above. The dimensions where we do lead are real, evidenced, and material to the use cases the platform is designed for.

Which to choose if...

• You are a large hospital running an enterprise procurement and want maximum clinical-grade safety: Progeny Clinical or Phenotips. Both have the institutional references, certifications, and operational longevity that procurement committees reward.
• You are a hospital committed to HL7 FHIR: TrakGene is structurally aligned.
• You are a cancer genetics service that wants BOADICEA v6 and Tyrer-Cuzick v8 bundled directly: FamGenix. The widest cancer-risk model bundle in any commercial platform.
• You want gesture-driven drawing during live consultation: Evagene. The only platform offering gesture-first input.
• You want the broadest single-platform feature surface in one tool: Evagene. Twenty algorithms + AI + API + MCP + 1,900-entry catalogue + OCR + karyogram in a single browser app.
• You want the most contemporary web UX: Evagene. Modern stack, gesture-first, dark mode, responsive.
• You are building AI agents or a bespoke integration, or you lead with AI-assisted draft summaries: Evagene. BYOK LLMs, MCP server, REST API, webhooks, embeddable viewer.
• You are a small clinic or solo counsellor wanting a credible free clinical-grade tool: Progeny Cloud.
• You are in an HPO-first rare disease diagnostics service: Phenotips.
• You are doing statistical genetics research on kinship and coefficients: QuickPed.
• You need Phenopackets v2 support for collaborative research: PedigreeTool (Stanford), or Evagene's Phenopackets v2 export.
• You want a research-, education-, and family-history-focused tool with the broadest feature surface, not a clinical-grade product: Evagene.

Frequently asked questions

Related guides

• Best free pedigree makers 2026
• Best pedigree software for genetic counsellors
• Best pedigree software for hospitals
• Best pedigree software for oncology
• Best hereditary cancer risk tools
• Clinical genetics pedigree tools: a field guide
• All Evagene comparisons